Technologies

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine

  • by

​ First and Only REN-Based Migraine Treatment Approved in China BEIJING and NETANYA, Israel, Sept. 30, 2025 /PRNewswire/ — Pier 88 Health, a digital health company dedicated to reshaping chronic pain management and bringing breakthrough global medical… Read More »Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine